Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
Go back to Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 311.02 +9.50 (3.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $301.52 | 52 Week High | $139.79 | |||
| Open | $299.78 | 52 Week Low | $82.07 | |||
| Day High | $313.30 | P/E | 723.30 | |||
| Day Low | $299.70 | EPS | $0.43 | |||
| Volume | 101,278 | |||||
| (NASDAQ: PIRS) | Delayed: 13.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.60 | 52 Week High | $3.08 | |||
| Open | $13.60 | 52 Week Low | $1.29 | |||
| Day High | $13.60 | P/E | N/A | |||
| Day Low | $13.60 | EPS | $0.00 | |||
| Volume | 14,671 | |||||
